Exploring Semaglutide's Impact on Heart Failure and Cardiovascular Health

This chapter delves into the STEP-HEF trial, examining how semaglutide positively affects patients with heart failure with preserved ejection fraction by enhancing quality of life and physical endurance. It emphasizes the importance of long-term studies in understanding the cardiovascular benefits of GLP-1 receptor agonists and compares them with conventional diet methods and bariatric surgery.